3
Total investments
0
Early stage
3
Mid stage
0
Late stage
7y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Mar 2022
Forestreet has built a SaaS Market and Vendor Discovery platform that uses AI to identify EVERY company within any market, broken down to product feature level. Their analytics are used globally by three of the ‘Big Four’ consultancies, major corporates and PE funds.
Board Member
Apr 2019
Doctify is a high-growth HealthTech company revolutionising the global healthcare market. Having expanded into 6 markets with an ambitious growth plan over the coming year.
Doctify has developed a first-of-its-kind healthcare-specific patient feedback and review product allowing healthcare professionals to drive improvements in patient care on a daily basis.
Our SaaS product allows healthcare providers to collect and digitize patient feedback and publish it through multiple channels (both externally and internally). Underpinning it is a SaaS platform that provides insights and analytics into the care they provide. It means for the first time patients can read real-time verified feedback for a hospital, clinic, or doctor for a specific condition or procedure.
The company was founded by two orthopaedic surgeons in 2015 with the goal of providing more trust and transparency in healthcare. It quickly grew from an idea to a revenue-generating business in less than a year and continues to thrive. Backed by industry-leading European funds Amadeus capital, Keen ventures as well as backers such Sir John Hegarty (the founder of Saatchi and Saatchi) and Tom Teichmann (backer of Lastminute.com, Not on the highstreet, Made.com, Simba Sleep).
Since then we have added over 25,000 doctors, hospitals, and clinics across 4 international markets, doubled our team across 6 countries and have won numerous awards along the way in recognition of our commitment to bringing greater levels of trust and transparency to the doctor-patient relationship. Most recently recognised as the 2021 Vitality Supplier of the Year.
Board Member
Apr 2019
At Thriva, we’re on a mission to help millions of people worldwide become actively invested in their long term health. Through using health insights to help them thrive.
Our consumer business is for everyone who wants to improve and understand what is happening inside their bodies. From taking a home test to getting actional results and GP advice all through a website and app.
Our B2B business, Thriva Solutions offers health services and provides a full end to end diagnostic service (DAAS). We offer speed, reduced risk and scaling of diagnostic capabilities for partners who work with us. We’re building a new category in the market and would love for you to come on this journey with us.
We’ve sent over 5 million test kits to hundreds of thousands of customers, giving them insights into their health, measuring things like nutrients, hormones, cholesterol, and also have an exciting clinical innovation pipeline, where we’re constantly looking to bring in new tests and testing modalities, such as sexual health screens, genetic testing, and urine testing.
With Thriva, you get:
- Personalised blood tests
- GP-reviewed results in 48 hours
- Evidence-based advice
Check your health as often as you like with our flexible subscription tests. We offer everything from monthly to annual options. And you can change, pause, delay, or cancel at any time.
How does it work?
1. Collect your sample — we’ll show you all the tips and tricks on how to collect your sample.
2. Label and post — send your sample and get results straight to the app within 48 hours.
3. Get personalised insights — understand how your lifestyle habits and blood test results can affect your health and how to improve it.
We never share or sell your medical information with third parties.
Experience · 6 entries
All (6)
Investments (3)
Board (3)
2022
Board Member
Mar 2022
Forestreet has built a SaaS Market and Vendor Discovery platform that uses AI to identify EVERY company within any market, broken down to product feature level. Their analytics are used globally by three of the ‘Big Four’ consultancies, major corporates and PE funds.
2019
Board Member
Apr 2019
Doctify is a high-growth HealthTech company revolutionising the global healthcare market. Having expanded into 6 markets with an ambitious growth plan over the coming year.
Doctify has developed a first-of-its-kind healthcare-specific patient feedback and review product allowing healthcare professionals to drive improvements in patient care on a daily basis.
Our SaaS product allows healthcare providers to collect and digitize patient feedback and publish it through multiple channels (both externally and internally). Underpinning it is a SaaS platform that provides insights and analytics into the care they provide. It means for the first time patients can read real-time verified feedback for a hospital, clinic, or doctor for a specific condition or procedure.
The company was founded by two orthopaedic surgeons in 2015 with the goal of providing more trust and transparency in healthcare. It quickly grew from an idea to a revenue-generating business in less than a year and continues to thrive. Backed by industry-leading European funds Amadeus capital, Keen ventures as well as backers such Sir John Hegarty (the founder of Saatchi and Saatchi) and Tom Teichmann (backer of Lastminute.com, Not on the highstreet, Made.com, Simba Sleep).
Since then we have added over 25,000 doctors, hospitals, and clinics across 4 international markets, doubled our team across 6 countries and have won numerous awards along the way in recognition of our commitment to bringing greater levels of trust and transparency to the doctor-patient relationship. Most recently recognised as the 2021 Vitality Supplier of the Year.
Board Member
Apr 2019
At Thriva, we’re on a mission to help millions of people worldwide become actively invested in their long term health. Through using health insights to help them thrive.
Our consumer business is for everyone who wants to improve and understand what is happening inside their bodies. From taking a home test to getting actional results and GP advice all through a website and app.
Our B2B business, Thriva Solutions offers health services and provides a full end to end diagnostic service (DAAS). We offer speed, reduced risk and scaling of diagnostic capabilities for partners who work with us. We’re building a new category in the market and would love for you to come on this journey with us.
We’ve sent over 5 million test kits to hundreds of thousands of customers, giving them insights into their health, measuring things like nutrients, hormones, cholesterol, and also have an exciting clinical innovation pipeline, where we’re constantly looking to bring in new tests and testing modalities, such as sexual health screens, genetic testing, and urine testing.
With Thriva, you get:
- Personalised blood tests
- GP-reviewed results in 48 hours
- Evidence-based advice
Check your health as often as you like with our flexible subscription tests. We offer everything from monthly to annual options. And you can change, pause, delay, or cancel at any time.
How does it work?
1. Collect your sample — we’ll show you all the tips and tricks on how to collect your sample.
2. Label and post — send your sample and get results straight to the app within 48 hours.
3. Get personalised insights — understand how your lifestyle habits and blood test results can affect your health and how to improve it.
We never share or sell your medical information with third parties.
2018
G
Guinness Asset Management
Investment Manager
Oct 2018
Investment Manager
Oct 2018
The Guinness Ventures team have been investing in early-stage businesses since 2010. We invest in outstanding entrepreneurs and businesses with disruptive and ambitious growth plans. We have successfully supported the growth of over 180 companies since 2010 and are always excited to meet passionate entrepreneurs.
Guinness EIS provides scale-up capital to private companies and Guinness AIM EIS invests in AIM-listed companies.
Guinness VCT seeks to invest in a portfolio of business that we believe provide the opportunity for growth and value appreciation. We are targeting an annual dividend of 5% from 2026.
Guinness Sustainable Estate Planning Service invests in renewable energy generating companies that qualify for Business Relief, helping investors pass more of their wealth onto their family.
Show all 6 entries ↓
Investment activity
2019–2022 · 3 investments
Recent (last 2 years)Earlier
